Intrinsic Value of S&P & Nasdaq Contact Us

Australis Capital Inc. AUSAF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
26/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Australis Capital Inc. (AUSAF) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 24/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
26/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
25/100
Debt-to-Equity & liquidity
→ Health
MOAT
35/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — AUSAF

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.16
Book Value / Share$0.00
Revenue / Share$0.03
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-37,881.00 $0.00 $-37.88K -
2017 $0.00 $0.00 $-42.7K -
2018 $-0.04 $129.76K $-4.17M -3214.4%
2019 $-0.14 $221.48K $-23.34M -10539%
2020 $-0.14 $717.15K $-25.26M -3522.4%
2021 $-0.16 $7.57M $-40.03M -528.7%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message